1.Research Progress of the Correlation between Caveolin and Unexpected Sudden Cardiac Death.
Fang Yu WU ; Lian Lei GAI ; Xiao Ping KONG ; Bo HAO ; Er Wen HUANG ; He SHI ; Li Hui SHENG ; Li QUAN ; Shui Ping LIU ; Bin LUO
Journal of Forensic Medicine 2017;33(3):284-288
Due to the negative autopsy and without cardiac structural abnormalities, unexpected sudden cardiac death (USCD) is always a tough issue for forensic pathological expertise. USCD may be associated with parts of fatal arrhythmic diseases. These arrhythmic diseases may be caused by disorders of cardiac ion channels or channel-related proteins. Caveolin can combine with multiple myocardial ion channel proteins through its scaffolding regions and plays an important role in maintaining the depolarization and repolarization of cardiac action potential. When the structure and function of caveolin are affected by gene mutations or abnormal protein expression, the functions of the regulated ion channels are correspondingly impaired, which leads to the occurrence of multiple channelopathies, arrhythmia or even sudden cardiac death. It is important to study the effects of caveolin on the functions of ion channels for exploring the mechanisms of malignant arrhythmia and sudden cardiac death.
Arrhythmias, Cardiac/physiopathology*
;
Autopsy
;
Caveolins/metabolism*
;
Channelopathies/genetics*
;
Death, Sudden, Cardiac/pathology*
;
Forensic Pathology
;
Humans
;
Ion Channels/metabolism*
;
Mutation
;
Myocardium
2.Zhuanggu Jianxi Decoction () limits interleukin-1 β-induced degeneration chondrocytes via the caveolin-p38 MAPK signal pathway.
Hu YAN ; You-xin SU ; Xue-yi LIN ; Bao-jun CHEN ; Qing ZHANG ; Zi-yi ZHANG ; Yi-ru WANG ; Ya-nan LI ; Mei-li LU ; Zhen HE ; Lu SHENG ; Wen-ting WANG
Chinese journal of integrative medicine 2014;20(5):353-359
OBJECTIVETo evaluate the effect of Zhuanggu Jianxi Decoction (, ZGJXD) on interleukin-1 β (IL-1 β)-induced degeneration of chondrocytes (CDs) as well as the activation of caveolin-p38 mitogen-activated protein kinase (MAPK) signal pathway, investigating the possible molecular mechanism that ZGJXD treats osteoarthritis.
METHODSSerum pharmacology was applied in the present study, where ZGJXD was orally administrated to New Zealand rabbits and then ZGJXD containing serum (ZGJXD-S) was collected for following in vitro experiments. CDs were isolated aseptically from New Zealand rabbits and then cultured in vitro. Upon IL-1 β stimulation, the degeneration of CDs was verified by inverted microscope, toluidine blue stain and type II collagen immunocytochemistry. After IL-1 β-stimulated CDs were intervened with blank control serum, ZGJXD-S, together with or without SB203580 (a specific inhibitor of p38 MAPK) for 48 h, caveolin-1 protein expression and the phosphorylation level of p38 were determined by Western blotting, and the mRNA expression of IL-1 β, tumor necrosis factor α (TNF-α), matrix metalloproteinase 3 (MMP-3) and MMP-13 were examined by real-time polymerase chain reaction.
RESULTSIL-1 β stimulation induced degeneration of CDs, increased caveolin-1 expression and p38 phosphorylation, up-regulated the mRNA level of IL-1 β, TNF-α, MMP-3 and MMP-13. However, the IL-1 β-induced activation of caveolin-p38 signaling and alteration in the expression of p38 downstream target genes were suppressed by ZGJXD-S and/or SB203580 in CDs.
CONCLUSIONZGJXD can prevent CDs degeneration via inhibition of caveolin-p38 MAPK signal pathway, which might be one of the mechanisms that ZGJXD treats osteoarthritis.
Animals ; Base Sequence ; Blotting, Western ; Caveolins ; metabolism ; Chondrocytes ; drug effects ; enzymology ; metabolism ; DNA Primers ; Drugs, Chinese Herbal ; pharmacology ; Gene Expression Profiling ; Interleukin-1beta ; physiology ; MAP Kinase Signaling System ; Male ; RNA, Messenger ; genetics ; Rabbits ; p38 Mitogen-Activated Protein Kinases ; genetics ; metabolism
3.High cholesterol level upregulate the expression of caveolin-1.
Yinwei RAN ; Junrong DU ; Bo BAI ; Rong ZHANG ; Zhongmin QIAN
Journal of Biomedical Engineering 2004;21(2):276-279
To study the influence of hypercholesterolemia with caveolin-1 on the plasmalemma of vascular endothelium, we used the methods of immunohistochemistry to detect the dynamic changes of caveolin-1 in cultured ECV-304 cells which were stimulated high cholesterol serum and the arterial endothelium of hypercholesterolemia rats. It is resulted that high cholesteorol level can upregulate the expression of caveolin-1 both in vitro and in vivo. In the initial stage of hypercholesterolemia model, the expression of caveolin-1 increased as the time of high cholesterol level added, but in the later period it was decreased slightly.
Animals
;
Aorta
;
pathology
;
Caveolin 1
;
Caveolins
;
biosynthesis
;
genetics
;
Cells, Cultured
;
Cholesterol
;
blood
;
Endothelium, Vascular
;
cytology
;
metabolism
;
Female
;
Humans
;
Hypercholesterolemia
;
metabolism
;
Male
;
Rabbits
;
Rats
;
Rats, Sprague-Dawley
;
Umbilical Veins
;
cytology
4.Co-localization and interaction of organic anion transporter 1 with caveolin-2 in rat kidney.
Jin Oh KWAK ; Hyun Woo KIM ; Kwang Jin OH ; Dong Su KIM ; Ki Ok HAN ; Seok Ho CHA
Experimental & Molecular Medicine 2005;37(3):204-212
The organic anion transporters (OAT) have recently been identified. Although the some transport properties of OATs in the kidney have been verified, the regulatory mechanisms for OAT's functions are still not fully understood. The rat OAT1 (rOAT1) transports a number of negatively charged organic compounds between the cells and their extracellular milieu. Caveolin (Cav) also plays a role in membrane transport. Therefore, we investigated the protein-protein interactions between rOAT1 and caveolin-2. In the rat kidney, the expressions of rOAT1 mRNA and protein were observed in both the cortex and the outer medulla. With respect to Cav-2, the expressions of mRNA and protein were observed in all portions of the kidney (cortex < outer medulla = inner medulla). The results of Western blot analysis using the isolated caveolae-enriched membrane fractions or the immunoprecipitates by respective antibodies from the rat kidney showed that rOAT1 and Cav-2 co-localized in the same fractions and they formed complexes each other. These results were confirmed by performing confocal microscopy with immunocytochemistry using the primary cultured renal proximal tubular cells. When the synthesized cRNA of rOAT1 along with the antisense oligodeoxynucleotides of Xenopus Cav-2 were co-injected into Xenopus oocytes, the [14C]p-aminohippurate and [3H]methotrexate uptake was slightly, but significantly decreased. The similar results were also observed in rOAT1 over-expressed Chinese hamster ovary cells. These findings suggest that rOAT1 and caveolin-2 are co-expressed in the plasma membrane and rOAT1's function for organic compound transport is upregulated by Cav-2 in the normal physiological condition.
Animals
;
Biological Transport, Active/*physiology
;
CHO Cells
;
Caveolins/*metabolism
;
Cell Membrane/*metabolism
;
Cells, Cultured
;
Hamsters
;
Immunoprecipitation
;
Kidney Tubules, Proximal/*metabolism
;
Methotrexate/metabolism
;
Microscopy, Confocal
;
Oligonucleotides, Antisense/pharmacology
;
Oocytes/metabolism
;
Organic Anion Transport Protein 1/antagonists & inhibitors/genetics/*metabolism
;
RNA, Complementary/metabolism
;
RNA, Messenger/genetics/metabolism
;
Rats
;
Research Support, Non-U.S. Gov't
;
Xenopus laevis/metabolism
;
p-Aminohippuric Acid/metabolism
5.Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.
Cristina CAPANNI ; Patrizia SABATELLI ; Elisabetta MATTIOLI ; Andrea OGNIBENE ; Marta COLUMBARO ; Giovanna LATTANZI ; Luciano MERLINI ; Carlo MINETTI ; Nadir M MARALDI ; Stefano SQUARZONI
Experimental & Molecular Medicine 2003;35(6):538-544
Dysferlin is a plasma membrane protein of skeletal muscle whose deficiency causes Miyoshi myopathy, limb girdle muscular dystrophy 2B and distal anterior compartment myopathy. Recent studies have reported that dysferlin is implicated in membrane repair mechanism and coimmunoprecipitates with caveolin 3 in human skeletal muscle. Caveolin 3 is a principal structural protein of caveolae membrane domains in striated muscle cells and cardiac myocytes. Mutations of caveolin 3 gene (CAV3) cause different diseases and where caveolin 3 expression is defective, dysferlin localization is abnormal. We describe the alteration of dysferlin expression and localization in skeletal muscle from a patient with raised serum creatine kinase (hyperCKaemia), whose reduction of caveolin 3 is caused by a CAV3 P28L mutation. Moreover, we performed a study on dysferlin interaction with caveolin 3 in C2C12 cells. We show the association of dysferlin to cellular membrane of C2C12 myotubes and the low affinity link between dysferlin and caveolin 3 by immunoprecipitation techniques. We also reproduced caveolinopathy conditions in C2C12 cells by a selective p38 MAP kinase inhibition with SB203580, which blocks the expression of caveolin 3. In this model, myoblasts do not fuse into myotubes and we found that dysferlin expression is reduced. These results underline the importance of dysferlin-caveolin 3 relationship for skeletal muscle integrity and propose a cellular model to clarify the dysferlin alteration mechanisms in caveolinopathies.
Animals
;
Biopsy
;
Caveolin 3
;
Caveolins/*genetics/metabolism
;
Cell Line
;
Creatine Kinase/*blood
;
Enzyme Inhibitors/*pharmacology
;
Humans
;
Imidazoles/pharmacology
;
Insulin/pharmacology
;
Membrane Proteins/*metabolism
;
Mice
;
Mitogen-Activated Protein Kinases/*antagonists & inhibitors/metabolism
;
Muscle Proteins/*metabolism
;
Muscle, Skeletal/cytology/metabolism
;
Mutation/*genetics
;
Protein Binding
;
Pyridines/pharmacology
;
p38 Mitogen-Activated Protein Kinases